Retinol‐Binding Protein 4 Promotes Cardiac Injury After Myocardial Infarction Via Inducing Cardiomyocyte Pyroptosis Through an Interaction With NLRP3
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Retinol‐Binding Protein 4 Promotes Cardiac Injury After Myocardial Infarction Via Inducing Cardiomyocyte Pyroptosis Through an Interaction With NLRP3
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 10, Issue 22, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2021-11-02
DOI
10.1161/jaha.121.022011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- Discovery of novel TNNI3K inhibitor suppresses pyroptosis and apoptosis in murine myocardial infarction injury
- (2020) Haiying Pang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Is the Retinol-Binding Protein 4 a Possible Risk Factor for Cardiovascular Diseases in Obesity?
- (2020) Anna Maria Rychter et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The pluripotent role of exosomes in mediating non-coding RNA in ventricular remodeling after myocardial infarction
- (2020) Zhongwen Qi et al. LIFE SCIENCES
- The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
- (2020) Allison K. Meyers et al. Cells
- Characterization of differentially expressed plasma proteins in patients with acute myocardial infarction
- (2020) Yilong Pan et al. Journal of Proteomics
- Plasma Membrane Pores Drive Inflammatory Cell Death
- (2020) Benedikt Kolbrink et al. Frontiers in Cell and Developmental Biology
- Retinol binding protein 4 (Rbp4) mRNA translation in hepatocytes is enhanced by activation of mTORC1
- (2020) Jaclyn E. Welles et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4
- (2020) Pedro M. Moraes-Vieira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders
- (2019) William S. Blaner PHARMACOLOGY & THERAPEUTICS
- Serum retinol-binding protein 4 is associated with the presence and severity of coronary artery disease in patients with subclinical hypothyroidism
- (2019) Hui-Xian Sun et al. Aging-US
- Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction
- (2019) Masafumi Takahashi JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The NLRP3 inflammasome in acute myocardial infarction
- (2019) Adolfo Gabriele Mauro et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- MiR-135b protects cardiomyocytes from infarction through restraining the NLRP3/caspase-1/IL-1β pathway
- (2019) Anqi Li et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- IFN Regulatory Factor 1 Mediates Macrophage Pyroptosis Induced by Oxidized Low-Density Lipoprotein in Patients with Acute Coronary Syndrome
- (2019) Min Guo et al. MEDIATORS OF INFLAMMATION
- Emerging Activators and Regulators of Inflammasomes and Pyroptosis
- (2019) Yansong Xue et al. TRENDS IN IMMUNOLOGY
- Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function
- (2018) Jonathon P. Audia et al. BASIC RESEARCH IN CARDIOLOGY
- New Insights Into the Role of mTOR Signaling in the Cardiovascular System
- (2018) Sebastiano Sciarretta et al. CIRCULATION RESEARCH
- Targeting TLRs and the inflammasome in systemic sclerosis
- (2018) John Henderson et al. PHARMACOLOGY & THERAPEUTICS
- Disruption of VEGF Mediated Flk‐1 Signaling Leads to a Gradual Loss of Vessel Health and Cardiac Function During Myocardial Infarction: Potential Therapy With Pellino‐1
- (2018) Mahesh Thirunavukkarasu et al. Journal of the American Heart Association
- The role of retinol-binding protein 4 and its relationship with sex hormones in coronary artery disease
- (2018) Hongxia Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Acute Myocardial Infarction
- (2017) Jeffrey L. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antigen Presentation and T-Cell Activation Are Critical for RBP4-Induced Insulin Resistance
- (2016) Pedro M. Moraes-Vieira et al. DIABETES
- Hepatocytes Are the Principal Source of Circulating RBP4 in Mice
- (2016) Spencer J. Thompson et al. DIABETES
- Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway
- (2016) Wei Gao et al. ENDOCRINOLOGY
- Novel role for retinol-binding protein 4 in the regulation of blood pressure
- (2015) Bettina J. Kraus et al. FASEB JOURNAL
- Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
- (2015) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Retinol Binding Protein 4 in Relation to Diet, Inflammation, Immunity, and Cardiovascular Diseases
- (2015) Fateme Zabetian-Targhi et al. Advances in Nutrition
- TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury
- (2014) Yi Liu et al. BASIC RESEARCH IN CARDIOLOGY
- Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease
- (2014) Vaia Lambadiari et al. Cardiovascular Diabetology
- RBP4 Activates Antigen-Presenting Cells, Leading to Adipose Tissue Inflammation and Systemic Insulin Resistance
- (2014) Pedro M. Moraes-Vieira et al. Cell Metabolism
- The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia–reperfusion injury
- (2013) Øystein Sandanger et al. CARDIOVASCULAR RESEARCH
- Retinol-binding protein 4 levels and susceptibility to ischaemic events in men
- (2013) Judit Cubedo et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Quantitative Measurement of Full-Length and C-Terminal Proteolyzed RBP4 in Serum of Normal and Insulin-Resistant Humans using a Novel Mass Spectrometry Immunoassay
- (2012) Qin Yang et al. ENDOCRINOLOGY
- Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome
- (2012) Nassrene Y. Elmadhun et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Retinol-Binding Protein 4 Induces Inflammation in Human Endothelial Cells by an NADPH Oxidase- and Nuclear Factor Kappa B-Dependent and Retinol-Independent Mechanism
- (2012) K. M. Farjo et al. MOLECULAR AND CELLULAR BIOLOGY
- Retinol-Binding Protein 4 Inhibits Insulin Signaling in Adipocytes by Inducing Proinflammatory Cytokines in Macrophages through a c-Jun N-Terminal Kinase- and Toll-Like Receptor 4-Dependent and Retinol-Independent Mechanism
- (2012) J. Norseen et al. MOLECULAR AND CELLULAR BIOLOGY
- Retinoic Acid Signalling Is Activated in the Postischemic Heart and May Influence Remodelling
- (2012) Dusan Bilbija et al. PLoS One
- Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury
- (2011) Masanori Kawaguchi et al. CIRCULATION
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
- (2011) E. Mezzaroma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the Mouse
- (2010) Erhe Gao et al. CIRCULATION RESEARCH
- Adipose Tissue Exosome-Like Vesicles Mediate Activation of Macrophage-Induced Insulin Resistance
- (2009) Z.-b. Deng et al. DIABETES
- Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy
- (2009) Peter Bobbert et al. EUROPEAN JOURNAL OF HEART FAILURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started